ElectromedELMD +2.72%91 FCF Yield % is 2.73 as of Jun. 26, 2026, which is 0% above its 10-year median of 2.72. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.16 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Electromed ranks better than 68.54% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Electromed FCF Yield % Related Terms
Electromed FCF Yield % Historical Data
* Premium members only.
The historical data trend for Electromed's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Electromed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromed FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromed's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Electromed's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Electromed (ELMD) has a FCF Yield % of 2.73 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Electromed and its competitors. This is near median its historical median of 2.72. According to the industry distribution chart, Electromed ranks #269 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 31.5%.
Is Electromed's FCF Yield % too high?
Electromed's current FCF Yield % of 2.73 is near median its 10-year median of 2.72. Based on the distribution chart, Electromed ranks #269 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's FCF Yield % compare to MASS and SI?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #269 out of 855 companies for FCF Yield %. This puts Electromed in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Electromed and its competitors. Electromed's current FCF Yield % is 2.73, which is near median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.16, compared to a current price of $41.14 — trading 63.5% above its estimated fair value. The current FCF Yield % is 2.73, which is near median its 10-year median of 2.72. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Electromed (ELMD), the current FCF Yield % is 2.73 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Electromed (ELMD) Overvalued in 2026?
Based on GuruFocus' analysis, Electromed stock appears to be overvalued.
The current stock price of $41.14 is trading 63.5% above its estimated GF Value™ of $25.16.
GuruFocus considers Electromed to be Significantly Overvalued.
Key valuation signals for ELMD:
FCF Yield %: 2.73 (near median its 10-year median of 2.72)
GF Value™: $25.16 vs. price of $41.14 (63.5% above fair value)
No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score
Get the complete analysis for ELMD
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELMD has been successfully added to your 
